BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18712992)

  • 21. Clinicopathologic features of six cases of primary cervical lymphoma.
    Chan JK; Loizzi V; Magistris A; Hunter MI; Rutgers J; DiSaia PJ; Berman ML
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):866-72. PubMed ID: 16150291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
    Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
    Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma.
    Gan H; Zhang F; Lin Y
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):397-9. PubMed ID: 12408775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrotizing leukoencephalopathy following CHOP chemotherapy.
    Blaes AH; Santa-Cruz KS; Lee CK; Hui SK; Peterson BA
    Leuk Res; 2008 Oct; 32(10):1611-4. PubMed ID: 18378307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
    Li YH; Jiang WQ; Huang HQ; Xu RH; Lin TY; Xia ZJ; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):401-3. PubMed ID: 12703998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.
    Heinz R; Pawlicki M; Losonczy H; Varbiro M; Benedek S; Konopka L; Krc I; Brugiatelli M
    Haematologica; 1986; 71(6):473-9. PubMed ID: 3104156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment strategy of high malignancy non-Hodgkin lymphomas].
    Pfreundschuh M; Trümper L
    Praxis (Bern 1994); 1998 Jun; 87(23):812-5. PubMed ID: 9654988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical investigations in aggressive non-Hodgkin lymphoma.
    Jonathan F
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary cervical epidural low-grade non-hodgkin's lymphoma: a case report and review of the literature].
    Lahiani Ben Salah H; Daoud J
    Cancer Radiother; 2008 Dec; 12(8):863-6. PubMed ID: 18565781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-hodgkin's malignant lymphoma in the uterine cervix].
    Makarewicz R; Swirska M; Terlikiewicz J
    Wiad Lek; 1993 Dec; 46(23-24):936-7. PubMed ID: 7900393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
    Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY; Xu RH; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
    Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
    Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by metaregression.
    Messori A; Fadda V; Maratea D; Trippoli S
    Am J Hematol; 2013 May; 88(5):435. PubMed ID: 23420571
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
    Ab Hamid S; Wastie ML
    Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary malignant non-Hodgkin's lymphoma of the heart].
    Iwuagwu OC; Kober R
    Rofo; 2002 Dec; 174(12):1578-9. PubMed ID: 12471533
    [No Abstract]   [Full Text] [Related]  

  • 40. [Non-Hodgkin's lymphoma: a new less toxic treatment doubles the prognosis].
    Sabourin G
    Perspect Infirm; 2012; 9(6):60. PubMed ID: 23234232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.